Learning may provide neuroprotection against dementia

West Indian Medical Journal

Volumn 51, Issue 3, 2002, Pages 143-147

  Youssef, F F ^a   Addae, J I ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; NEUROTRANSMITTER;

ACADEMIC ACHIEVEMENT; ARTICLE; BRAIN FUNCTION; CELL PROTECTION; CLINICAL FEATURE; CLINICAL STUDY; COGNITION; CORRELATION ANALYSIS; DEMENTIA; EDUCATION; HEALTH STATUS; HIPPOCAMPUS; HUMAN; HYPOXIA; LEARNING; LIFESTYLE; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; NERVE CELL; NERVE CELL STIMULATION; NEUROPROTECTION; OBSERVATION; PATHOGENESIS; PATHOPHYSIOLOGY; RISK FACTOR; SENSITIVITY ANALYSIS;

ALZHEIMER DISEASE; ANIMALS; DEMENTIA; EDUCATIONAL STATUS; GLUTAMIC ACID; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; RISK FACTORS;

EID: 0036759324     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Castillo-Salgado C. Health Situation Analysis in the Americas, 1999-2000. Epidemiological Bulletin, PAHO 2000; 21: 1-3.
2. WHO. Life in the 21st century: a vision for all. World Health Report 1998: 100-2.
3. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993; 43: 13-20.
4. Friedland RP. Epidemiology, education, and the ecology of Alzheimer's disease. Neurology 1993; 43: 246-9.
5. Rocca WA, Bonaiuto S, Lippi A, Luciani P, Turtu F, Cavarzeran F et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology 1990; 40: 626-31.
6. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Brit Med J 1995; 310: 970-3.
7. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271: 1004-10.
8. Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428-37.
9. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991; 41: 1886-92.
10. Ott A, van Rossum CT, van Harkskamp F, van de Mheen H, Hofman A, Breteler MM. Education and the incidence of dementia in a large population-based study: the Rotterdam Study. Neurology 1999; 52: 663-6.
11. Letenneur L, Launer LJ, Andersen K, Dewey ME, Ott A, Copeland JR et al. Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am J Epidemiol 2000; 151: 1064-71.
12. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke 1998; 29: 75-81.
13. Stern Y, Alexander GE, Prohovnik I, Mayeux R. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992; 32: 371-5.
14. Stern Y, Tang MX, Denaro J, Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995; 37: 590-5.
15. Geerlings MI, Deeg DJ, Schmand B, Lindeboom J, Jonker C. Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study. Neurology 1997; 49: 798-802.
16. Beard CM, Kokmen E, Offord KP, Kurland LT. Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology 1992; 42: 2063-8.
17. Moceri VM, Kukull WA, Emanuel I, van Belle G, Larson EB. Early-life risk factors and the development of Alzheimer's disease. Neurology 2000; 54: 415-20.
18. Greenamyre JT, Porter RH. Anatomy and physiology of glutamate in the CNS. Neurology 1994; 44: 7-13.
19. Hosli E, Hosli L. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog Neurobiol 1993; 40: 477-506.
20. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998; 54: 581-618.
21. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-9.
22. Bunsey M, Eichenbaum H. Critical role of the parahippocampal region for paired-associate learning in rats. Behav Neurosci 1993; 107: 740-7.
23. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa, S. Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 1993; 75: 1253-62.
24. Abeliovich A, Paylor R, Chen C, Kim JJ, Wehner JM, Tonegawa S. PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell 1993; 75: 1263-71.
25. Bennett MR. The concept of long term potentiation of transmission at synapses. Prog. Neurobiol. 2000; 60: 109-37.
26. Riedel G, Wetzel W, Reymann KG. (R,S)-alpha-methyl-4-carboxyphenylglycine (MCPG) blocks spatial learning in rats and long-term potentiation in the dentate gyrus in vivo. Neurosci Lett 1994; 167: 141-4.
27. Doble A. Excitatory amino acid receptors and neurodegeneration. Therapie 1995; 50: 319-37.
28. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984; 43: 1369-74.
29. Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor anatagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol 1999; 380: 91-9.
30. Hicks CA, Ward MA, Swettenham JB, O'Neill MJ. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor anatagonist with nitric oxide synthase inhibitors in global cerebral ischaemia. Euro J Pharmacol 1999; 381: 113-9.
31. Priestley T, Marshall GR, Hill RG, Kemp JA. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Brit J Pharmacol 1998; 124: 1767-73.
32. Moroney JT, Bagiella E, Desmond DW, Paik MC, Stern Y, Tatemichi TK. Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders. Stroke 1996; 27: 1283-9.
33. De la Monte SM, Neely TR, Cannon J, Wands JR. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 2000; 57: 1471-81.
34. Youssef FF, Addae JI, McRae A, Stone TW. Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia. Brain Res 2001; 907: 144-50.
35. Perez-Pinzon MA, Mumford PL, Rosenthal M, Sick TJ. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 1996; 75: 687-94.
36. Perez-Pinzon MA, Born JG, Centeno JM. Calcium and increase excitability promote tolerance against anoxia in hippocampal slices. Brain Res 1999; 833: 20-6.
37. Schurr A, Payne RS, Tseng MT, Gozal E, Gozal D. Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices. Neurosci Lett 2001; 307: 151-4.
38. Butcher SP, Davis S, Morris RG. A dose-related impairment of spatial learning by the NMDA receptor antagonist, 2-amino-5-phosphonovalerate (AP5). Eur Neuropsychopharmacol 1990; 1: 15-20.
39. Pringle AK, Iannotti F, Wilde GJ, Chad JE, Seeley PJ, Sundstrom LE. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res 1997; 755: 36-46.
40. Youssef F, Stone TW, Addae JI. Interactions of glutamate receptor agonists with long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 2000; 398: 349-59.
41. Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F. Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Brit J Pharmacol 1999; 128: 1035-44.
42. Lloyd HG, Lindstrom K, Fredholm BB. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int 1993; 23:173-85.
43. Dale N, Pearson T, Frenguelli BG. Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J Physiol 2000; 526: 143-55.
44. Coelho JE, de Mendonca A, Ribeiro JA. Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices. Brain Res 2000; 869: 158-65.
45. Jin S, Fredholm BB. Adenosine A1 receptors mediate hypoxia-induced inhibition of electrically evoked transmitter release from rat striatal slices. Eur J Pharmacol 1997; 329: 107-13.
46. Canhao P, de M, Ribeiro JA. 1,3-Dipropyl-8-cyclopentylxanthine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res 1994; 661: 265-73.
47. Fowler JC. Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus. Brain Res 1990; 509: 331-4.
48. Nikbakht M, Stone TW. Suppression of presynaptic responses to adenosine by activation of NMDA receptors. Eur J Pharmacol 2001, 427: 13-25.
49. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K et al. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 1999; 284: 1811-6.
50. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999; 284: 1805-11.